The most recent listing of current clinical trials for genitourinary cancers — including prostate, bladder, testicular and kidney — appears below. Should you be interested in learning more about any of these clinical trials, please use our Contact Us form.
Site: Genitourinary
(Includes Prostate, Bladder, Testicular and Kidney)
| Protocol ID |
|
Title |
|
| E1808 |
|
A Randomized Phase II Trial of Sunitinib/ Gemcitabine or Sunitinib in Advanced Renal Cell Carcinoma with Sarcomatoid Features
Keywords: Renal Cell Carcinoma with Sarcomatoid Features |
|
| RTOG 0534 |
|
A Phase III Trial of Short Term Androgen Deprivation with Pelvic Lymph Node or Prostate Bed Only Radiotherapy (SPPORT) in Prostate Cancer Patients with a Rising PSA After Radical Prostatectomy
Keywords: Prostate Cancer Patients with a Rising PSA After Radical Prostatectomy |
|
| In-House |
|
Management of Intra-Fractional Prostate Motion During Radiation Therapy
Keywords: radiation therapy |
|
| In-House |
|
A Phase II Trial of High-Dose Pelvic Lymph Node IMRT (Intensity Modulated Radiation Therapy) and Hypofractionated Prostate IMPRT for High Risk Prostate Cancer Patients
Keywords: High Risk Prostate Cancer Patients |
|
| In-House: BCG |
|
Safety of Biclutamide in chemoprevention of transitional cell carcinoma of the bladder treated with BCG
Keywords: transitional cell carcinoma of the bladder treated with BCG |
|
| In-House |
|
Urinary HMGB1 in Subjects with Urologic Diseases
Keywords: urologic diseases |
|
| In-house |
|
Prostate Cancer, Prostate Tissue, Quantitative Measurements of Parameters Governing Thermoacoustic Contrast
Keywords: Prostate Cancer |
|
| RTOG 0815 |
|
A Phase III Prospective Randomized Trial of Dose-Escalated Radiotherapy with or without Short Term Androgen Deprivation Therapy for Patients with Intermediate-Risk Prostate Cancer
Keywords: Intermediate-Risk Prostate Cancer |
|
| E3805 |
|
CHAARTED: ChemoHormonal Therapy v. Androgen Ablation Randomized Trial for Extensive Disease in Prostate Cancer
Keywords: Extensive Disease in Prostate Cancer |
|
| GU09-145 |
|
Phase I/II Study of BNC105P in Combination with Everolimus or Following Everolimus for Progressive Metastatic Clear Cell Renal Cell Carcinoma Following Prior Tyrosine Kinase Inhibitors
Keywords: Progressive Metastatic Clear Cell Renal Cell Carcinoma |
|
| In-House |
|
MicroRNA Distribution along Human Nephrons Bank
Keywords: bank |
|
| RTOG0924 |
|
Androgen Deprivation Therapy and High Dose Radiotherapy with or without Whole Pelvic Radiotherapy in Unfavorable Intermediate or Favorable High Risk Prostate Cancer: A Phase III Randomized Trial
Keywords: High Risk Prostate Cancer |
|
| UC 09-128B |
|
The Impact of a Decision Aid for Hormone Therapy for Prostate Cancer Recurrence on Patients Anxiety, Decisional Conflict, and Knowledge: A Randomized Trial
Keywords: Prostate Cancer Recurrence |
|
| In-House — MRI |
|
Investigation of the Utility of Advanced MRI Imagine Methods for Radiation Therapy Treatment Planning
Keywords: Advanced MRI Imagine Methods for Radiation Therapy Treatment Planning (Brain, Breast, Head & Neck, Lung, Cervix, Sarcoma, Prostate, or Liver and Liver Mets) |